Pascal Grandé

Pascal Grandé focuses on intellectual property law, particularly in the areas of national and international patent litigation.

Prior to earning his second state exam, Pascal served as a legal trainee and intern in Munich and London where he worked on product liability and patent litigation projects and on M&A transactions.

Experiência

BioMarin pursues litigation against Ascendis Pharma A/S in UPCJones Day represents BioMarin Pharmaceutical, Inc. in patent infringement proceedings against Ascendis Pharma A/S for infringement of European patent EP 3 175 863 B1 at the Unified Patent Court (UPC) in Munich, Germany. The patent covers long-acting variants of C-Type Natriuretic Peptide ("CNP").

Affiliates of Centre Lane Partners acquire substantially all of the assets of Hardinge Inc. and its subsidiaries, including the Kellenberger, USACH, SuperPrecision, and Workholding business linesJones Day advised affiliates of Centre Lane Partners in the acquisition of substantially all of the assets of Hardinge Inc. and its debtor subsidiaries, a global leader and provider of advanced machine tool, manufacturing and workholding solutions, as part of chapter 11 proceedings in the United States Bankruptcy Court for the District of Delaware.

Vibrantz moves to invalidate sinter paste patent before Unified Patent Court in MunichJones Day represents Vibrantz GmbH, a manufacturer of specialty chemicals and materials, in patent invalidation counterclaim proceedings before the Unified Patent Court, Munich local division, in a dispute over certain precious metal sinter pastes for chip bonding.

Vibrantz defends patent dispute before Unified Patent Court in MunichJones Day represents Vibrantz GmbH, a manufacturer of specialty chemicals and materials, in patent litigation before the Unified Patent Court, Munich local division, in a dispute over certain precious metal sinter pastes for chip bonding.

TotalEnergies acquires Quadra EnergyJones Day advised TotalEnergies SE in the acquisition of Quadra Energy GmbH.

Affinity Partners leads €207 million Series F financing of EGYMJones Day represented Affinity Partners in its acquisition of an interest in EGYM, a global fitness technology and corporate health innovation leader, in a Series F financing of €107 million, with an additional €100 million available for future investments.

Tikehau Capital leads €13 million Series A funding of Build38 GmbHJones Day advised Tikehau Capital as lead investor in the €13 million Series A financing of Build38 GmbH, a leading provider of mobile application protection solutions that combine AI-powered threat intelligence and the strongest app shielding technology, with subsidiaries in Spain and Singapore.

CJ CheilJedang defends German patent infringement action by Japanese competitorJones Day represented CJ CheilJedang Corporation, a major Korean-based multinational company, in an international patent dispute with a Japanese competitor before the courts in Germany, including the Federal Supreme Court of Germany.

UPL sells stake in Advanta Enterprises to KKRJones Day advised UPL Limited in its $300 million sale of a 13.33% stake in its subsidiary, Advanta Enterprises Limited, to KKR.

Findos Investor sells Rhenoflex GmbH to Coats GroupJones Day advised Findos Investor GmbH in the €115 million sale of Rhenoflex GmbH, one of the leading global manufacturers of sustainable structural material solutions for the footwear industry, to Coats Group plc.

Associate

Conectar

Experiência

Information on Opting European Patents Out of the UPC System

Information on Requesting a Unitary Patent

Exclusive and Non-Exclusive Licenses: Opportunities and Pitfalls Before the UPC

Pascal Grandé

Associate

Conectar

Compartilhe

Áreas de enfoque

Escritório

Educação

Membro

Idiomas